- Mar 25
CAR T cell therapy for pediatric patients: What parents should know
CAR T cell therapy is a type of immunotherapy that modifies T cells, so they can detect and fight cancer cells. This therapy is...
- Mar 7
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...
- Feb 7
Beyond chemotherapy: Navigating the promise and perils of CAR-T therapy in pediatric cancer
Upon hearing the phrase ‘cancer treatment’, the first word that can typically spring to mind is chemotherapy – a primary therapy which...
- Dec 21, 2023
Rethinking the Development of CAR T-Cell Products for Pediatric Cancer
In a commentary published in the Journal of Clinical Oncology, Claudia Rossig, MD, of the department of pediatric hematology and oncology...
- Dec 7, 2023
Promising target for CAR T cells helps cancer trick the immune system
Scientists at St. Jude Children’s Research Hospital showed that GRP78 is a promising but complex target for CAR T–cell immunotherapy...
- Nov 3, 2023
NIH researchers develop approach that could help supercharge T-cell therapies against solid tumors
Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based...
- Aug 23, 2023
Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights
Researchers from UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute have unveiled findings that shed light on why...
- May 11, 2023
Advanced immunotherapy treatment may hold promise for children with brain cancer
WEHI researchers have found promise in treating DIPG with an innovative new immunotherapy treatment, called CAR T therapy. Read more:...